TAMPA, Fla. (AP) — TAMPA, Fla. (AP) — Pacira Pharmaceuticals Inc. (PCRX) on Tuesday reported a loss of $10.1 million in its fourth quarter.
On a per-share basis, the Tampa, Florida-based company said it had a loss of 22 cents. Earnings, adjusted for one-time gains and costs, came to 80 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 80 cents per share.
The specialty drugmaker posted revenue of $172 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $174.1 million.
For the year, the company reported profit of $15.9 million, or 34 cents per share. Revenue was reported as $666.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a PCRX">Zacks stock report on PCRX at https://www.zacks.com/ap/PCRX